Literature DB >> 12191596

Cholinergic innervation and function in the prostate gland.

S Ventura1, J Pennefather, Frederick Mitchelson.   

Abstract

The mammalian prostate is densely innervated by hypogastric and pelvic nerves that play an important role in regulating the growth and function of the gland. While there has been much interest in the role of the noradrenergic innervation and adrenoceptors in prostate function, the role of cholinergic neurones in prostate physiology and pathophysiology is not well understood. This review focuses on the role of acetylcholine and cholinoceptors in prostate function. Nitric oxide, vasoactive intestinal polypeptide, and/or neuropeptide Y are co-localised with cholinesterase and/or acetylcholine transporter in some of the nerve fibres supplying the prostate. Their roles are also briefly discussed in this review. A dense network of cholinesterase-staining fibres supplies both prostate epithelium and stroma, suggesting a role of acetylcholine and/or co-localised neuropeptides in the modulation of prostatic secretions, as well as smooth muscle tone. A predominantly epithelial location for prostate muscarinic receptors indicated a major secretomotor role for acetylcholine. The muscarinic receptor subtype mediating muscarinic agonist-induced smooth muscle contraction or enhancement of contractions evoked by nerve stimulation differs in different species. In the human, there is evidence for M(1) receptors on the epithelium, M(2) receptors on the stroma, and both M(1) and M(3) receptors in some prostate cancer cell lines. Several recent investigations indicate that muscarinic receptors may also mediate or modulate normal, benign, and malignant prostate growth. The role of muscarinic agonists and their receptors and the influences of age, testicular, and other steroids in regulating the effects are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191596     DOI: 10.1016/s0163-7258(02)00174-2

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  22 in total

1.  Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells.

Authors:  V Sydorenko; Y Shuba; S Thebault; M Roudbaraki; G Lepage; N Prevarskaya; R Skryma
Journal:  J Physiol       Date:  2003-05-01       Impact factor: 5.182

2.  The residual nonadrenergic contractile response to nerve stimulation of the mouse prostate is mediated by acetylcholine but not ATP in a comparison with the mouse vas deferens.

Authors:  Carl W White; Jennifer L Short; John M Haynes; Richard J Evans; Sabatino Ventura
Journal:  J Pharmacol Exp Ther       Date:  2010-08-19       Impact factor: 4.030

3.  Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer.

Authors:  Sara Karami; Gabriella Andreotti; Stella Koutros; Kathryn Hughes Barry; Lee E Moore; Summer Han; Jane A Hoppin; Dale P Sandler; Jay H Lubin; Laurie A Burdette; Jeffrey Yuenger; Meredith Yeager; Laura E Beane Freeman; Aaron Blair; Michael C R Alavanja
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-05       Impact factor: 4.254

Review 4.  Neural regulation of hematopoiesis, inflammation, and cancer.

Authors:  Maher Hanoun; Maria Maryanovich; Anna Arnal-Estapé; Paul S Frenette
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

5.  A temporal and spatial map of axons in developing mouse prostate.

Authors:  Anne E Turco; Mark T Cadena; Helen L Zhang; Jaskiran K Sandhu; Steven R Oakes; Thrishna Chathurvedula; Richard E Peterson; Janet R Keast; Chad M Vezina
Journal:  Histochem Cell Biol       Date:  2019-04-11       Impact factor: 4.304

6.  Signal transduction by M3 muscarinic acetylcholine receptor in prostate cancer.

Authors:  Liqiang Guo; Yuqiang Liu; Zhibo Ding; Wendong Sun; Mingzhen Yuan
Journal:  Oncol Lett       Date:  2015-10-27       Impact factor: 2.967

7.  Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia.

Authors:  Dong Soo Park; Taek Woo Cho; Yong Kyu Lee; Young Tae Lee; Young Kwon Hong; Woong Ki Jang
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

8.  M3 subtype of muscarinic receptors mediate Ca2+ release from intracellular stores in rat prostate neuroendocrine cells.

Authors:  Jin Kyoung Kim; Soo Jung Kim; Ji Eun Lee; Kyeong Min Min; Sung Joon Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 9.  Muscarinic acetylcholine receptor subtypes in the male reproductive tract: expression and function in rat efferent ductules and epididymis.

Authors:  Maria Christina W Avellar; Erica R Siu; Fabiana Yasuhara; Elisabeth Maróstica; Catarina S Porto
Journal:  J Mol Neurosci       Date:  2009-08-20       Impact factor: 3.444

Review 10.  Hitting below the belt (bladder): botulinum treatment of urethral and prostate disorders.

Authors:  H Henry Lai; Christopher P Smith
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.